ENFN

Enfusion, Inc. [ENFN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ENFN Stock Summary

Top 10 Correlated ETFs

ENFN


Top 10 Correlated Stocks

ENFN


In the News

09:17 29 Sep 2023 ENFN

The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023

Finding undervalued stocks is one of the key strategies for successful investing. Undervalued stocks are those that trade below their intrinsic value, meaning that the market has not fully recognized their “true potential.

02:02 29 Sep 2023 ENFN

Enfusion, Inc. (ENFN) Q2 2023 Earnings Call Transcript

Enfusion, Inc. (NYSE:ENFN ) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Iggy Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants Kevin McVeigh - Credit Suisse Parker Lane - Stifel James Faucette - Morgan Stanley Callie Valenti - Goldman Sachs Dylan Becker - William Blair Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion Second Quarter 2023 Earnings Conference Call.

11:25 29 Sep 2023 ENFN

Here's What Key Metrics Tell Us About Enfusion, Inc. (ENFN) Q2 Earnings

While the top- and bottom-line numbers for Enfusion, Inc. (ENFN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

10:40 29 Sep 2023 ENFN

Enfusion, Inc. (ENFN) Q2 Earnings and Revenues Lag Estimates

Enfusion, Inc. (ENFN) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.04 per share a year ago.

08:30 29 Sep 2023 ENFN

Enfusion Announces Date of Second Quarter 2023 Results

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced it will release its second quarter 2023 financial results before the U.S. financial markets open on Tuesday, August 8, 2023. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results. To access this call, dial (888) 330-2502. The.

12:54 29 Sep 2023 ENFN

META vs. ENFN: Which Stock Should Value Investors Buy Now?

Investors with an interest in Internet - Software stocks have likely encountered both Meta Platforms (META) and Enfusion, Inc. (ENFN). But which of these two stocks presents investors with the better value opportunity right now?

11:55 29 Sep 2023 ENFN

Enfusion: H2 2023 Growth Acceleration Is The Catalyst To Share Price Rerating

I believe Enfusion is undervalued and poised for recovery, despite short-term financial challenges due to macro turmoil. The company's ability to sign new hedge funds and its international growth opportunities are positive indicators for future growth acceleration. ENFN valuation compared to expected revenue growth shows potential for closing the gap with competitors like FactSet.

03:31 29 Sep 2023 ENFN

Enfusion, Inc. (ENFN) Q1 2023 Earnings Call Transcript

Enfusion, Inc. (NYSE:ENFN ) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ET Company Participants Ignatius Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants Dylan Becker - William Blair James Faucette - Morgan Stanley J. Parker Lane - Stifel Nicolaus Koji Ikeda - Bank of America Operator Good morning, ladies and gentlemen.

08:24 29 Sep 2023 ENFN

Bull Of The Day: Enfusion (ENFN)

This stock has some good historical and projected topline growth.

07:54 29 Sep 2023 ENFN

Enfusion, Inc. (ENFN) Flat As Market Sinks: What You Should Know

In the latest trading session, Enfusion, Inc. (ENFN) closed at $8.56, marking no change from the previous day.

ENFN Financial details

Company Rating
Buy
Market Cap
762.8M
Income
8.71M
Revenue
163.36M
Book val./share
0.54
Cash/share
0.31
Dividend
-
Dividend %
-
Employees
1.01K
Optionable
No
Shortable
Yes
Earnings
23 Nov 2023
P/E
89.95
Forward P/E
-
PEG
-8.73
P/S
4.63
P/B
16.28
P/C
28.47
P/FCF
50.85
Quick Ratio
3.85
Current Ratio
4.33
Debt / Equity
0.27
LT Debt / Equity
0.17
-
-
EPS (TTM)
0.1
EPS next Y
-
EPS next Q
-
EPS this Y
-95.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
4.27%
EPS Q/Q
-81.06%
-
-
-
-
SMA20
12.5%
SMA50
-18.18%
SMA100
-
Inst Own
53.1%
Inst Trans
1.02%
ROA
9%
ROE
15%
ROC
0.14%
Gross Margin
68%
Oper. Margin
7%
Profit Margin
5%
Payout
-
Shs Outstand
85.23M
Shs Float
35.35M
-
-
-
-
Target Price
-
52W Range
7.37-14.61
52W High
-36.96%
52W Low
+26.07%
RSI
51
Rel Volume
0.19
Avg Volume
432.65K
Volume
83.55K
Perf Week
-2.81%
Perf Month
7.89%
Perf Quarter
-10.86%
Perf Half Y
-12.36%
-
-
-
-
Beta
-
-
-
Volatility
0.12%, 0.25%
Prev Close
-0.51%
Price
8.825
Change
1.09%

ENFN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
0.921.241.351.76
Net income per share
0.20.06-3.4-0.16
Operating cash flow per share
0.190.0300.17
Free cash flow per share
0.12-0.05-0.10.07
Cash per share
0.090.220.780.73
Book value per share
-1.84-3.650.670.76
Tangible book value per share
-1.84-3.651.171.21
Share holders equity per share
-1.84-3.650.670.76
Interest debt per share
0.441.560.060.09
Market cap
1.27B1.27B1.74B825.75M
Enterprise value
1.29B1.35B1.67B770.19M
P/E ratio
100.28312.53-6.16-62.26
Price to sales ratio
21.515.9515.575.49
POCF ratio
103.13762.26-5.47K58.33
PFCF ratio
161.12-372.95-208.71132.65
P/B Ratio
-10.77-5.4331.4512.7
PTB ratio
-10.77-5.4331.4512.7
EV to sales
21.8717.0114.995.12
Enterprise value over EBITDA
85.93160.27-6.13-137.05
EV to operating cash flow
104.9813.09-5.27K54.41
EV to free cash flow
163.89-397.82-200.98123.73
Earnings yield
0.010-0.16-0.02
Free cash flow yield
0.01000.01
Debt to equity
-0.23-0.4200.11
Debt to assets
1.192.5200.06
Net debt to EBITDA
1.4510.020.249.89
Current ratio
22.7111.065.57
Interest coverage
19.163.65-60.05-28.97
Income quality
0.970.410-1.07
Dividend Yield
0.01000
Payout ratio
0.871.14-0.010
Sales general and administrative to revenue
0.280.451.350.46
Research and developement to revenue
0.070.081.370.11
Intangibles to total assets
0000
Capex to operating cash flow
-0.36-3.0425.2-0.56
Capex to revenue
-0.08-0.06-0.07-0.05
Capex to depreciation
-3.83-2.21-2.02-1.25
Stock based compensation to revenue
002.590.17
Graham number
2.862.287.141.63
ROIC
-0.15-0.04-5-0.16
Return on tangible assets
0.550.1-2.66-0.11
Graham Net
-2-3.90.840.76
Working capital
8.1M18.26M81.57M79.43M
Tangible asset value
-117.88M-233.56M97.44M103.44M
Net current asset value
-124.91M-243.75M81.03M76.47M
Invested capital
-0.23-0.4200.11
Average receivables
010.58M15.2M22.04M
Average payables
0463.5K1.51M2.11M
Average inventory
0003.05M
Days sales outstanding
55.555.8859.5562.77
Days payables outstanding
9.538.2728.9813.06
Days of inventory on hand
00047.31
Receivables turnover
6.586.536.135.82
Payables turnover
38.2944.1312.627.95
Inventory turnover
0007.71
ROE
-0.11-0.02-5.1-0.2
Capex per share
-0.07-0.08-0.1-0.09

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
0.430.460.470.460.48
Net income per share
-0.050.030.010.050.01
Operating cash flow per share
0.030.090.090.010.07
Free cash flow per share
0.010.080.07-0.020.04
Cash per share
0.670.750.730.610.31
Book value per share
0.70.720.760.720.54
Tangible book value per share
1.181.211.211.120.82
Share holders equity per share
0.70.720.760.720.54
Interest debt per share
000.090.170.15
Market cap
863.57M1.05B825.75M933.06M990.88M
Enterprise value
807.01M987.28M770.19M892.12M975.93M
P/E ratio
-52.34101.12261.9849.69393.83
Price to sales ratio
23.6326.8420.3822.7723.19
POCF ratio
298.81134109.791.01K164.65
PFCF ratio
1.08K151.85142.99-573.84260.83
P/B Ratio
14.617.1912.714.6520.59
PTB ratio
14.617.1912.714.6520.59
EV to sales
22.0925.2219.0121.7722.84
Enterprise value over EBITDA
-206.66215.19247.65136.26215.53
EV to operating cash flow
279.24125.9102.41965.5162.17
EV to free cash flow
1.01K142.67133.37-548.66256.89
Earnings yield
0000.010
Free cash flow yield
00.010.0100
Debt to equity
000.110.210.27
Debt to assets
000.060.110.14
Net debt to EBITDA
14.48-13.85-17.86-6.25-3.3
Current ratio
9.178.015.576.324.33
Interest coverage
-3.91K735.253.243.50
Income quality
-0.73.029.540.26.03
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.50.330.370.350.38
Research and developement to revenue
0.10.10.120.110.1
Intangibles to total assets
00000
Capex to operating cash flow
-0.72-0.12-0.23-2.76-0.37
Capex to revenue
-0.06-0.02-0.04-0.06-0.05
Capex to depreciation
-1.3-0.54-1.03-1.37-1.07
Stock based compensation to revenue
0.210.010.1-0.030.06
Graham number
0.880.70.40.920.3
ROIC
-0.070.040.010.050.03
Return on tangible assets
-0.040.020.010.040.01
Graham Net
0.820.870.760.60.31
Working capital
80.41M84.04M79.43M72.94M45.87M
Tangible asset value
99.81M103.17M103.44M99.15M72.24M
Net current asset value
79.93M83.6M76.47M64.3M37.82M
Invested capital
000.110.210.27
Average receivables
26.09M28.88M27.42M25.11M24.76M
Average payables
1.03M1.03M1.44M1.49M1.08M
Average inventory
4.55M3.12M4.36M5.85M5.28M
Days sales outstanding
70.8666.6557.4353.553.03
Days payables outstanding
7.298.9111.418.735.5
Days of inventory on hand
30.1519.5841.3237.8931.46
Receivables turnover
1.271.351.571.681.7
Payables turnover
12.3410.17.8910.3116.37
Inventory turnover
2.984.62.182.382.86
ROE
-0.070.040.010.070.01
Capex per share
-0.02-0.01-0.02-0.03-0.03

ENFN Frequently Asked Questions

What is Enfusion, Inc. stock symbol ?

Enfusion, Inc. is a US stock , located in Chicago of Il and trading under the symbol ENFN

What is Enfusion, Inc. stock quote today ?

Enfusion, Inc. stock price is $8.825 today.

Is Enfusion, Inc. stock public?

Yes, Enfusion, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap